Atlas Trials

Resilient Pharmaceuticals

30 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Resilient Pharmaceuticals

RecordFirmDate
Study of Midomafetamine in Healthy Adults (NCT07584720)Resilient Pharmaceuticals2026-04-23
A Multi-Site Study of MDMA-Assisted Psychotherapy for Eating Disorders (NCT04454684)Resilient Pharmaceuticals2026-02-01
Psychological Effects of Methylenedioxymethamphetamine (MDMA) When Administered to Healthy Volunteers (MT-2) (NCT04073433)Resilient Pharmaceuticals2024-12-01
Study of Feasibility and Safety of MDMA-Assisted Group Therapy for the Treatment of PTSD in Veterans (NCT05173831)Resilient Pharmaceuticals2023-09-01
Study of Safety and Effects of MDMA-assisted Therapy for Treatment of PTSD (NCT04968938)Resilient Pharmaceuticals2022-08-01
Food Effects on Bioavailability of MDMA in Healthy Volunteers (NCT05147402)Resilient Pharmaceuticals2022-07-28
Study Comparing Two Versus Three Active MDMA-assisted Sessions in U.S. Military Veterans With Chronic PTSD (NCT04784143)Resilient Pharmaceuticals2021-11-08
A Multi-Site Open-Label Extension Study of MDMA-Assisted Psychotherapy for PTSD (NCT04714359)Resilient Pharmaceuticals2021-03-08
Long-Term Safety and Effectiveness of MDMA-Assisted Therapy for PTSD (NCT05066282)Resilient Pharmaceuticals2021-03-01
A Multi-Site Phase 3 Study of MDMA-Assisted Psychotherapy for PTSD (MAPP2) (NCT04077437)Resilient Pharmaceuticals2020-09-02
A Multi-Site Phase 3 Study of MDMA-Assisted Psychotherapy for PTSD (MAPP1) (NCT03537014)Resilient Pharmaceuticals2018-11-21
Study of Safety and Effects of MDMA-assisted Psychotherapy for Treatment of PTSD (Canada) (NCT03485287)Resilient Pharmaceuticals2018-03-13
Open Label Multi-Site Study of Safety and Effects of MDMA-assisted Therapy for Treatment of PTSD (NCT03282123)Resilient Pharmaceuticals2017-11-16

Track Resilient Pharmaceuticals automatically

Every clearance here is in the API, with alerts when new ones post.